Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages 1278-1288

  Legler, Juliette ^a   Fletcher, Tony ^b   Govarts, Eva ^c   Porta, Miquel ^d,e,f   Blumberg, Bruce ^g   Heindel, Jerrold J ^h   Trasande, Leonardo ^i,j,k,l  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f Institut d'Investigació en Atenció Primària IDIAP Jordi Gol Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP   (Spain)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NEW YORK UNIVERSITY   (United States)

^k NEW YORK UNIVERSITY   (United States)

^l NEW YORK UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; PHTHALIC ACID; PHTHALIC ACID DERIVATIVE; POLLUTANT;

ADULT; ARTICLE; CHILD; CHILDHOOD OBESITY; CLIMATE CHANGE; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; EUROPEAN UNION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; OBESITY; OBSERVATIONAL STUDY; PEER REVIEW; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROBABILITY; REFERENCE VALUE; SCHOOL CHILD; SENSITIVITY ANALYSIS; AGED; CHEMICALLY INDUCED; ECONOMICS; MIDDLE AGED; OVERWEIGHT; POLLUTANT; STATISTICS AND NUMERICAL DATA; TOXICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHILD; COST OF ILLNESS; DIABETES MELLITUS; DICHLORODIPHENYL DICHLOROETHYLENE; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EUROPEAN UNION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PHTHALIC ACIDS;

EID: 84927594365     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4326     Document Type: Article

References (84)

1. OECD. Health at a Glance: Europe 2012. Overweight and obese among adults. http://www.oecd-ilibrary.org/sites/9789264183896-en/02/07/index.html?itemId=/content/chapter/9789264183896-26-en. Accessed September 22, 2014.
2. OECD. Health at a Glance: Europe 2012. Overweight and obesity among children. Available at http://www.oecd-ilibrary.org/sites/9789264183896-en/02/02/index.html?itemId=/content/chapter/9789264183896-26-en&-csp-=051b7f1a7a00be030 ba5033520b8c1ba. Accessed August 25, 2014).
3. International Diabetes Foundation. Europe. http://www.idf.org/diabetesatlas/europe. Accessed September 22, 2014.
4. Trasande L, Cronk C, Durkin M, et al. Environment and obesity in the National Children's Study. Environ Health Perspect. 2009;117:159-166.
5. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. NEngl JMed. 2005;352:1138-1145.
6. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007;357:2371-2379.
7. Trasande L. How much should we invest in preventing childhood obesity? Health Aff (Millwood). 2010;29:372-378.
8. Trasande L, Liu Y, Fryer G, Weitzman M. Effects of childhood obesity on hospital care and costs, 1999-2005. Health Aff (Millwood). 2009;28:w751-w760.
9. Trasande L, Chatterjee S. The impact of obesity on health service utilization and costs in childhood. Obesity (Silver Spring). 2009;17:1749-1754.
10. Trasande L, Elbel B. The economic burden placed on healthcare systems by childhood obesity. Expert Rev Pharmacoecon Outcomes Res. 2012;12:39-45.
11. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:293-301.
12. Porta M. Persistent organic pollutants and the burden of diabetes. Lancet. 2006;368:558-559.
13. Gasull M, Pumarega J, Téllez-Plaza M, et al. Blood concentrations of persistent organic pollutants and prediabetes and diabetes in the general population of Catalonia. Environ Sci Technol. 2012;46:7799-7810.
14. Grün F, Watanabe H, Zamanian Z, et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol. 2006;20:2141-2155.
15. Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol. 2009;304:43-48.
16. Song Y, Hauser R, Hu FB, Franke AA, Liu S, Sun Q. Urinary concentrations of bisphenol A and phthalate metabolites and weight change: a prospective investigation in US women. Int J Obes (Lond). 2014;38:1532-1537.
17. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U. S. males. Environ Health Perspect. 2007;115:876-882.
18. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA. 2012;308:1113-1121.
19. Carwile JL, Michels KB. Urinary bisphenolAand obesity: NHANES 2003-2006. Environ Res. 2011;111:825-830.
20. Lee DH, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ Health Perspect. 2010;118:1235-1242.
21. Feige JN, Gelman L, Rossi D, et al. The endocrine disruptor monoethylhexyl-phthalate is a selective peroxisome proliferator-activated receptor γ modulator that promotes adipogenesis. J Biol Chem. 2007;282:19152-19166.
22. Feige JN, Gerber A, Casals-Casas C, et al. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARα-dependent mechanisms. Environ Health Perspect. 2010;118:234-241.
23. Lee DH, Porta M, Jacobs DR Jr, Vandenberg LN. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev. 2014;35:557-601.
24. Janesick A, Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today. 2011;93:34-50.
25. Alonso-Magdalena P, Morimoto S, Ripoll C, et al. The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ Health Perspect. 2006;114:106-112.
26. Masuno H, Kidani T, Sekiya K, et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res. 2002;43:676-684.
27. Gillman MW, Barker D, Bier D, et al. Meeting report on the 3rd international congress on developmental origins of health and disease (DOHaD). Pediatr Res. 2007;61:625-629.
28. Janesick AS, Shioda T, Blumberg B. Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol. 2014;398:31-35.
29. Trasande L. Further limiting bisphenol A in food uses could provide health and economic benefits. Health Aff (Millwood). 2014;33:316-323.
30. Trasande L, Liu Y. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Aff (Millwood). 2011;30:863-870.
31. Institute of Medicine. Costs of Environment-Related Health Effects. Washington, DC: National Academy Press; 1981.
32. Pruss-Ustun A, Vickers C, Haefliger P, Bertollini R. Knowns and unknowns on burden of disease due to chemicals: a systematic review. Environ Health. 2011;10:9.
33. Intergovernmental Panel on Climate Change. Guidance notes for lead authors of the IPCC Fourth Assessment Report on addressing uncertainties. http://www.ipcc.ch/meetings/ar4-workshops-expressmeetings/uncertainty-guidance-note.pdf. Accessed May 12, 2014. 2005.
34. United Nations Environment Programme (Stockholm Convention Secretariat). Stockholm Convention on persistent organic pollutants. http://chm.pops.int/default.aspx. Accessed December 8, 2010.
35. Trasande L, Zoeller RT, Hass U, et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100:1245-1255.
36. Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res. 2004;4:38.
37. Schünemann HJ, Schünemann AH, Oxman AD, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106-1110.
38. European Union. Roadmap for evaluation of endocrine disruptor chemicals. http://ec.europa.eu/smart-regulation/impact/planned-ia/docs/2014-env-009-endocrine-disruptors-en. pdf. Accessed October 15, 2014.
39. Hass U, Christiansen S, Axelstad M, et al. Evaluation of 22 SIN List 2.0 substances according to the Danish proposal on criteria for endocrine disrupters. http://eng.mst.dk/media/mst/67169/SIN%20report%20and%20Annex.pdf. Accessed May 12, 2014.
40. Iszatt N, et al. Prenatal and postnatal exposure to POPs and infant growth: a pooled analysis of 7 European birth cohorts. Environ Health Perspect. In press.
41. Monteiro PO, Victora CG. Rapid growth in infancy and childhood and obesity in later life-a systematic review. Obes Rev. 2005;6:143-154.
42. Valvi D, Mendez MA, Martinez D, et al. Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study. Environ Health Perspect. 2012;120:451-457.
43. Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: Systematic reviews and hopeful suggestions. Acta Paediatr. 2006;95:904-908.
44. Levin M. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9:531-541.
45. United Nations Economic Commission for Europe. Population, 5-year age groups, by sex. http://w3.unece.org/pxweb/Dialog/varval.asp?ma=001-GEPOAGESEX-REG-r&ti=Population% 2C+5-year+age+groups%2C+by+Age%2C+Sex%2C+Country+ and+Year&path=../DATABASE/Stat/30-GE/01-Pop/&lang=1. Accessed August 26, 2014.
46. Wu H, Bertrand KA, Choi AL, et al. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses' health study and meta-analysis. Environ Health Perspect. 2013;121:153-161.
47. Langenberg C, Sharp S, Forouhi NG, et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 2011;54:2272-2282.
48. Turyk M, Anderson H, Knobeloch L, Imm P, Persky V. Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect. 2009;117:1076-1082.
49. OECD. Health at a glance: Europe 2012. Prevalence estimates of diabetes mellitus, adults aged 20-79 years. http://www.keepeek. com/Digital-Asset-Management/oecd/social-issues-migration-health/health-at-a-glance-europe-2012/diabetes-prevalence-and-incidence-9789264183896-17-en# page1. Accessed August 26, 2014.
50. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557-567.
51. Sun Q, Cornelis MC, Townsend MK, et al. Association of urinary concentrations of bisphenol A and phthalate metabolites with risk of type 2 diabetes: a prospective investigation in the Nurses' Health Study (NHS) and NHSII cohorts. Environ Health Perspect. 2014;122:616-623.
52. Valvi D, Casas M, Mendez MA, et al. Prenatal bisphenol a urine concentrations and early rapid growth and overweight risk in the offspring. Epidemiology. 2013;24:791-799.
53. Gladen BC, Klebanoff MA, Hediger ML, et al. Prenatal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect. 2004;112:1761-1767.
54. Cupul-Uicab LA, Klebanoff MA, Brock JW, Longnecker MP. Prenatal exposure to persistent organochlorines and childhood obesity in the US collaborative perinatal project. Environ Health Perspect. 2013;121:1103-1109.
55. Valvi D, Mendez MA, Garcia-Esteban R, et al. Prenatal exposure to persistent organic pollutants and rapid weight gain and overweight in infancy. Obesity (Silver Spring). 2014;22:488-496.
56. Mendez MA, Garcia-Esteban R, Guxens M, et al. Prenatal organochlorine compound exposure, rapid weight gain, and overweight in infancy. Environ Health Perspect. 2011;119:272-278.
57. Warner M, Aguilar Schall R, Harley KG, Bradman A, Barr D, Eskenazi B. In utero DDT and DDE exposure and obesity status of 7-year-old Mexican-American children in the CHAMACO Scohort. Environ Health Perspect. 2013;121:631-636.
58. Warner M, Wesselink A, Harley KG, Bradman A, Kogut K, Eskenazi B. Prenatal exposure to dichlorodiphenyltrichloroethane and obesity at 9 years of age in the CHAMACOS study cohort. Am J Epidemiol. 2014;179:1312-1322.
59. Tang-Péronard JL, Heitmann BL, Andersen HR, et al. Association between prenatal polychlorinated biphenyl exposure and obesity development at ages 5 and 7 y: a prospective cohort study of 656 children from the Faroe Islands. Am J Clin Nutr. 2014;99:5-13.
60. Jusko TA, Koepsell TD, Baker RJ, et al. Maternal DDT exposures in relation to fetal and 5-year growth. Epidemiology. 2006;17:692-700.
61. Lee DH, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6:e15977.
62. Rignell-Hydbom A, Lidfeldt J, Kiviranta H, et al. Exposure to p, p'-DDE: a risk factor for type 2 diabetes. PLoS One. 2009;4:e7503.
63. Rajesh P, Balasubramanian K. Phthalate exposure in utero causes epigenetic changes and impairs insulin signalling. J Endocrinol. 2014;223:47-66.
64. Lind PM, Roos V, Ronn M, et al. Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women. Environ Health. 2012;11:21.
65. Teitelbaum SL, Mervish N, Moshier EL, et al. Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res. 2012;112:186-193.
66. Hurst CH, Waxman DJ. Activation of PPARα and PPARγ by environmental phthalate monoesters. Toxicol Sci. 2003;74:297-308.
67. Harley KG, Aguilar Schall R, Chevrier J, et al. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect. 2013;121:514-520.
68. Braun JM, Lanphear BP, Calafat AM, et al. Early-life bisphenol a exposure and child body mass index: a prospective cohort study. Environ Health Perspect. 2014;122:1239-1245.
69. van Esterik JC, Dollé ME, Lamoree MH, et al. Programming of metabolic effects in C57BL/6JxFVB mice by exposure to bisphenol A during gestation and lactation. Toxicology. 2014;321:40-52.
70. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet. 2010;376:1775-1784.
71. Scarborough P, Bhatnagar P, Wickramasinghe KK, Allender S, Foster C, Rayner M. The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs. J Public Health (Oxf). 2011;33:527-535.
72. Pruss-Ustun A, Vickers C, Haefliger P, Bertollini R. Knowns and unknowns on burden of disease due to chemicals: a systematic review. Environ Health. 2011;10:9.
73. Porta M, Zumeta E. Implementing the Stockholm Treaty on persistent organic pollutants. Occup Environ Med. 2002;59:651-652.
74. Gascon M, Vrijheid M, Garí M, et al. Temporal trends in concentrations and total serum burdens of organochlorine compounds from birth until adolescence and the role of breastfeeding. Environ Int. 2015;74:144-151.
75. Halldorsson TI, Rytter D, Haug LS, et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect. 2012;120:668-673.
76. Barry V, Darrow LA, Klein M, Winquist A, Steenland K. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure. Environ Res. 2014;132:62-69.
77. Li X, Pham HT, Janesick AS, Blumberg B. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor γ (PPARγ). Environ Health Perspect. 2012;120:1720-1726.
78. Brown VJ. Potential obesogen identified: fungicide triflumizole is associated with increased adipogenesis in mice. Environ Health Perspect. 2012;120:A474.
79. Damstra T, Barlow S, Bergman A, Kavlock RJ, van der Kraak G, eds. Global Assessment of the State-of-the-Science of Endocrine Disruptors. Geneva, Switzerland: World Health Organization; 2002.
80. Legler J. An integrated approach to assess the role of chemical exposure in obesity. Obesity (Silver Spring). 2013;21:1084-1085.
81. Leigh JP, Markowitz SB, Fahs M, Shin C, Landrigan PJ. Occupational injury and illness in the United States. Estimates of costs, morbidity, and mortality. Arch Intern Med. 1997;157:1557-1568.
82. Fahs MC, Markowitz SB, Fischer E, Shapiro J, Landrigan PJ. Health costs of occupational disease in New York state. Am J Ind Med. 1989;16:437-449.
83. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect. 2002;110:721-728.
84. Arrow KJ, Cropper ML, Eads GC, et al. Is there a role for benefitcost analysis in environmental, health, and safety regulation? Science. 1996;272:221-222.